Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer
Số trang: 13
Loại file: pdf
Dung lượng: 1.73 MB
Lượt xem: 8
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
To assess construct validity and responsiveness of the Expanded Prostate Cancer Index Composite Instrument (EPIC-26) relative to the Short-Form Six-Dimension (SF-6D) and Assessment of Quality of Life 6-Dimension (AQoL-6D) in patients following treatment for prostate cancer.
Nội dung trích xuất từ tài liệu:
Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer
Nội dung trích xuất từ tài liệu:
Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Construct validity Convergent validity Discriminant validity Prostate cancer Clinical trials makes Intra-class correlation coefficientGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 171 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 142 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 118 0 0 -
12 trang 93 0 0
-
19 trang 74 0 0
-
17 trang 63 0 0
-
9 trang 43 0 0
-
12 trang 38 0 0
-
Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer
17 trang 37 0 0